메뉴 건너뛰기




Volumn 47, Issue 6, 2004, Pages 976-977

Response to Chiasson et al.: Acarbose for the prevention of Type 2 diabetes, hypertension and cardiovascular disease in subjects with impaired glucose tolerance: Facts and interpretations concerning the critical analysis of the STOP-NIDDM Trial data

Author keywords

[No Author keywords available]

Indexed keywords

ACARBOSE; PLACEBO;

EID: 3142746834     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-004-1410-y     Document Type: Note
Times cited : (13)

References (8)
  • 1
    • 1842833530 scopus 로고    scopus 로고
    • Acarbose for prevention of diabetes, hypertension and cardiovascular events? A critical analysis of the STOP-NIDDM data
    • Kaiser T, Sawicki PT (2004) Acarbose for prevention of diabetes, hypertension and cardiovascular events? A critical analysis of the STOP-NIDDM data. Diabetologia 47:575-580
    • (2004) Diabetologia , vol.47 , pp. 575-580
    • Kaiser, T.1    Sawicki, P.T.2
  • 2
    • 0031682113 scopus 로고    scopus 로고
    • The STOP-NIDDM Trial. An international study on the efficacy of an α-glucosidase inhibitor to prevent type 2 diabetes in a population with impaired glucose tolerance: Rationale, design, and preliminary screening data
    • Chiasson J-L, Gomis R, Hanefeld M et al. (1998) The STOP-NIDDM Trial. An international study on the efficacy of an α-glucosidase inhibitor to prevent type 2 diabetes in a population with impaired glucose tolerance: rationale, design, and preliminary screening data. Diabetes Care 21:1720-1725
    • (1998) Diabetes Care , vol.21 , pp. 1720-1725
    • Chiasson, J.-L.1    Gomis, R.2    Hanefeld, M.3
  • 3
    • 0038455703 scopus 로고    scopus 로고
    • Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance. The STOP-NIDDM Trial
    • Chiasson JL, Josse RG, Gomis R et al. (2003) Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance. The STOP-NIDDM Trial. JAMA 290:486-494
    • (2003) JAMA , vol.290 , pp. 486-494
    • Chiasson, J.L.1    Josse, R.G.2    Gomis, R.3
  • 4
    • 0037097039 scopus 로고    scopus 로고
    • Acarbose for prevention of type 2 diabetes mellitus: The STOP-NIDDM randomised trial
    • Chiasson JL, Josse RG, Gomis R et al. (2002) Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial. Lancet 359:2072-2077
    • (2002) Lancet , vol.359 , pp. 2072-2077
    • Chiasson, J.L.1    Josse, R.G.2    Gomis, R.3
  • 5
    • 85003347069 scopus 로고    scopus 로고
    • Acarbose for patients with hypertension and impaired glucose tolerance
    • Kaiser T, Sawicki PT (2003) Acarbose for patients with hypertension and impaired glucose tolerance. JAMA 290:3066
    • (2003) JAMA , vol.290 , pp. 3066
    • Kaiser, T.1    Sawicki, P.T.2
  • 6
    • 1642326305 scopus 로고    scopus 로고
    • Practice guidelines for primary care physicians: 2003 ESH/ESC hypertension guidelines
    • Cifkova R, Erdine S, Fagard R et al. (2003) Practice guidelines for primary care physicians: 2003 ESH/ESC hypertension guidelines. J Hypertens 21:1779-1786
    • (2003) J Hypertens , vol.21 , pp. 1779-1786
    • Cifkova, R.1    Erdine, S.2    Fagard, R.3
  • 7
    • 0346727578 scopus 로고    scopus 로고
    • Acarbose reduces the risk for myocardial infarction in type 2 diabetic patients: Meta-analysis of seven long-term studies
    • Hanefeld M, Cagatay M, Petrowitsch T et al. (2004) Acarbose reduces the risk for myocardial infarction in type 2 diabetic patients: meta-analysis of seven long-term studies. Eur Heart J 25:10-16
    • (2004) Eur Heart J , vol.25 , pp. 10-16
    • Hanefeld, M.1    Cagatay, M.2    Petrowitsch, T.3
  • 8
    • 0033046464 scopus 로고    scopus 로고
    • A randomized double-blind trial of acarbose in type 2 diabetes shows improved glycemic control over 3 years
    • Holman RR, Cull CA, Turner RC (1999) A randomized double-blind trial of acarbose in type 2 diabetes shows improved glycemic control over 3 years. Diabetes Care 22:960-964
    • (1999) Diabetes Care , vol.22 , pp. 960-964
    • Holman, R.R.1    Cull, C.A.2    Turner, R.C.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.